https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
The distribution of pediatric-onset morphea and site-based likelihood for extracutaneous complications has not been well characterized. To characterize the lesional distribution of pediatric-onset morphea and to determine the sites with the highest association of extracutaneous manifestations. A retrospective cross-sectional study was performed. Using clinical photographs, morphea lesions were mapped onto body diagrams using customized software. A total of 823 patients with 2522 lesions were included. Lesions were m